Good Manufacturing Practices (GMP) Induced Pluripotent Stem Cell (iPSC) Reprogramming, Gene Editing And Differentiation
Source: OmniaBio
CCRM has extensive experience in cell reprogramming using a variety of gene editing tools to enable the development of iPSC and iPSC-derived therapeutics.
- 200+ reprogrammed iPS lines and 15+ gene-edited IPS lines; iPS scaled to 10 L
- Experience in optimization of various differentiation processes (to blood and non-blood lineages) and enabling transition from 2D to 3D culture